Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

The fact is, no one knows what next fall will bring, and few posters here are equipped to make performance projections based on success and failure.

If I had time I'd go through my algorithm and crunch numbers, but here are the bottom lines I get:

After September:

Prurisol and Kevetrin both successful with high efficacy: $30-$50 a share pending the first deal.

Prurisol or Kevetrin high efficacy with one or the other inconclusive: $10-$15, pending the first deal for the successful one.

Prurisol and Kevetrin both inconclusive, but worth continuing for the next round of clinicals: $5

Both Prurisol and Kevetrin fail to provide efficacy: No bottom until a return to 10 cents.

One more comment, all the data you are looking for is now moot with both drugs entering or in trials. The only thing that counts now is how they perform in humans.